Companion Animal TREATMENT: HYPERADRENOCORTICISM (CUSHING S SYNDROME) IN DOGS
|
|
- Dwayne McBride
- 6 years ago
- Views:
Transcription
1 Edward C. Feldman, DVM Diplomate ACVIM (SAIM), Professor Emeritus, Small Animal Internal Medicine University of California Davis, California TREATMENT: HYPERADRENOCORTICISM (CUSHING S SYNDROME) IN DOGS TREATING DOGS FOR NATURALLY OCCURRING CUSHING S SYNDROME The Good The goals in treating dogs afflicted with naturally occurring Cushing s syndrome (pituitary dependent hyperadrenocorticism, PDH; or adrenocortical tumor hyperadrenocorticism, ACT) are to resolve the clinical signs and improve both dog and owner s quality of life. It is critically important, however, for owners to understand their role on the veterinary-owner-patient team. Major decisions are made based on owner observations and are keys to long-term success. Success rates with several forms of treatment have been excellent. Signs resolve in a typical order, with polyphagia being the first sign to improve in most dogs. Owners also note that their dogs begin to be more active and pant less, as polydipsia and polyuria resolve. All these can begin to resolve in just days to a few weeks. Muscle strength and pot belly take longer to resolve and the various skin and hair coat issues may require months. Why is all this important? It has been shown that as these signs resolve, there is parallel improvement in hypertension, susceptibility to infection, proteinuria, and other concerns. The Bad It must be pointed out that some dogs with Cushing s syndrome have severe arthritis, immune-mediated conditions, chronic kidney disease, or other problems masked by their Cushing s syndrome and revealed with therapy. Arthritis can be quite alarming. It is a concern we mention to all owners of dogs with Cushing s syndrome who are >20 kg in weight. The anti-inflammatory effects of cortisol in dogs are striking. For example, the combination of hyperadrenocorticism and pancreatitis is quite unusual. However, after Cushing s has been successfully treated, this inflammatory condition becomes far more common. A few treated dogs have seemed to develop cancer soon after therapy for Cushing s, begging the question of whether the Cushing s had been masking cancer. Similarly, a small percentage of dogs with PDH begin exhibiting clinical signs of a pituitary macro-tumor soon after being treated. Again, was the excess cortisol suppressing tumor-associated inflammation or slowing growth? The Ugly Dogs with severe alopecia, secondary to Cushing s syndrome tend to slowly have return of a hair coat as treatment progresses. Sometimes these dogs develop a puppy coat before developing their normal adult hair coats. Some dogs with PDH, with treatment, actually change hair coat color, with the most common change being that the coat is far darker. Dogs that have what appears to be a partial or full hair coat before treatment may go through a period in which they shed their truncal coats and have severe skin flaking. This can be quite alarming or bothersome to owners. It is our experience, however, that this period of shedding and flaking is associated with excellent response to treatment and is usually followed by return of a full hair coat. However, a puppy coat or change in coat color does happen on occasion. SURGICAL REMOVAL OF ADRENAL AND PITUITARY TUMORS Surgical removal of an autonomously functioning, glucocorticoid-secreting, adrenocortical tumor (ACT), causing hyperadrenocorticism, is the treatment of choice in dogs and cats. This surgery is increasingly being done with laparoscopy. Surgical removal of a pituitary tumor causing hyperadrenocorticism (PDH) is the standard treatment strategy for people. Pituitary surgery has been utilized with dogs and cats with PDH, but only a few veterinary surgeons have been trained in this procedure. It is anticipated that this form of treatment will become standard in the future as expertise is gained. MEDICAL THERAPY USING o,p DDD Background Mitotane (Lysodren, o,p -DDD) is a derivative of the insecticide DDT. Research completed in the 1940 s demonstrated that this drug was an adrenocorticolytic agent (causing cell death and necrosis) of canine adrenal cortices. In most treated dogs, the zona fasciculata and zona reticularis are damaged or destroyed while the mineralocorticoid-producing zona glomerulosa is spared or less damaged. While
2 this drug is relatively ineffective in the treatment of hyperadrenocorticism in people and cats, it is quite effective in dogs with PDH. However, if too little medication is given, hyperadrenocorticism fails to resolve and if too much is given, life threatening hypocortisolism or hypoadrenocorticism (including destruction of the zona glomerulosa; Addison s disease) can occur. The goal in therapy: make the owner happy. In other words, resolving clinical signs is the best measure of success in resolving the biochemical and other issues associated with chronic circulating excesses in cortisol. Induction Protocol Lysodren (o,p DDD) therapy should always be initiated at home, on a Sunday, with the owner administering 25 mg/kg, BID, after feeding their dog. Glucocorticoids are not routinely administered and are not routinely dispensed. Rather, the owner should receive thorough education on the actions of o,p DDD and instructions to begin reducing their dog s food allotment by one-third beginning one or two days before o,p - DDD is begun. In other words, we have owners give their dog one-third of its normal food allotment twice daily, beginning on a Friday or Saturday. This should make the typical polyphagic Cushing s dog even more hungry. NOTE: NO DOG WITH A POOR APPETITE SHOULD EVER RECEIVE THIS DRUG! o,p -DDD administration should be continued twice daily until (1) the dog s daily water consumption approaches 60 ml/kg; (2) the dog simply takes longer to consume a meal and certainly before it develops partial or complete inappetence; (3) vomiting; (4) diarrhea, or (5) unusual listlessness. Any of these signs is an indication that the owner should stop daily o,p DDD therapy and have the dog examined by the veterinarian. The goal is simply to have the owner observe their dog eat. They should stop medication should any reduction in appetite be seen. Anorexia indicates that too much medication has been given or that a new problem has developed. The single most reliable and consistent indicator for stopping the induction phase of therapy is appetite. Any reduction in appetite indicates that the induction phase of therapy has been completed. Decreasing appetite is usually the first evidence of o,p -DDD action, usually noted in 4 to 9 days. Water intake in polydipsic dogs decreases, in more than 90% of dogs, within 5 to 10 days. In all, response takes as few as 3 or as long as 35 days, but the vast majority exhibit response within 4 10 days. Lysodren therapy can be quite successful in eliminating signs of Cushing s. Use of this drug is most effective if there is close communication between owner and veterinarian. Either the veterinarian or a technician should call the owner every day beginning with the second day of therapy. Owners usually become impressed with their veterinarian s concern and begin to observe their dog more closely after several phone calls. We advise our clients to feed their dogs 2 small meals each day. The dog s appetite should be observed prior to every o,p DDD administration. If food is rapidly consumed, medication can be given. If food is consumed slowly, incompletely, or not at all, the medication should not be given until the veterinarian is consulted. Reduction in appetite always indicates the end of therapy s induction phase. In addition to making daily phone calls, the veterinarian should see the dog 8 to 9 days after beginning therapy, sooner if decreased appetite is noted. Owners should bring urine collected from their dog the morning of any examination. At each examination, a thorough history, physical examination, urine specific gravity, a check for glucose in the urine, and an ACTH response test should be performed. Dogs that appear to have responded to the medication (or if the owner is not certain) should have therapy withheld until results of an ACTH response test can be evaluated. The goals of therapy with o,p DDD are to achieve resolution of clinical signs and an ACTH response test that is suggestive of relative hypoadrenocorticism. In our clinic, clinical success with o,p DDD is defined by an owner while biochemical success is indicated by pre- and post ACTH serum cortisol concentrations >1.5 and <5 µg/dl. If the dog with hyperadrenocorticism has a normal or exaggerated response to ACTH following the initial 8 to 9 days of o,p DDD therapy, daily medication should be continued for 3 to 7 additional days (this is quite unusual). ACTH response tests should be repeated every 7 to 10 days until the post-acth plasma cortisol is in the basal cortisol reference range (usually µg/dl). It is important to emphasize that each dog must be treated as an individual. There appears to be no reliable method of predicting the length of time required for a response or the amount of o,p DDD therapy
3 required except to state that most dogs respond in 5 9 days. It is unusual for a dog to require more than 9 consecutive days of o,p DDD. Approximately 10% of dogs with PDH are not polydipsic. They, too, can and should be treated by their owners at home. Absence of polydipsia simply eliminates one of the factors that can be monitored during the initial phases of therapy. Therapy will be based on history, physical examination and ACTH response test results. The most important monitoring guide in these dogs is no different than for polydipsic dogs, it is their appetite. Reduction in appetite in any dog receiving o,p DDD is an indication that the induction phase is completed or that over dosage is imminent. Maintenance Therapy The maintenance phase of therapy with o,p DDD may be initiated once a dog with Cushing s demonstrates a post-acth plasma cortisol in the basal cortisol reference range (usually µg/dl). Lysodren does not affect the pituitary. Therefore, the excessive ACTH secretion associated with PDH continues or becomes exaggerated with therapy. Failure to chronically continue o,p DDD therapy will result in re-growth of the adrenal cortices and return of clinical signs. This recurrence typically takes place within 1 to 12 months of stopping therapy. Maintenance therapy involves choosing an o,p DDD protocol and altering that regimen as required by the dog. Dogs that respond to daily o,p DDD therapy within 5-7 days are usually started on a maintenance schedule of 25 mg/kg/wk of o,p DDD. Those that initially require 7-10 days of therapy are typically given about 35 mg/kg/wk. An ACTH response test is performed 1 and 3 months after beginning the maintenance therapy, and every 3 to 6 months thereafter. If the plasma cortisol concentration after ACTH administration is in the reference range or elevated, the o,p DDD dosage or the frequency of administration is increased. If the post- ACTH plasma cortisol concentration is <1.5 µg/dl (sometimes <2.0 µg/dl) the dose should be decreased. If a dog receiving o,p DDD ever becomes ill, NO o,p DDD should be given. Let me provide an example of long-term treatment and its adjustments. A 20 kg dog has Cushing s and responds after 6 days of o,p -DDD. The dog is then placed on 25 mg/ kg/week (500 mg/week; o,p -DDD is provided as 500 mg tablets). Specifically, the dog is placed on one-fourth tablet (125 mg) orally, after eating, on Mondays, Tuesdays, Thursdays and Fridays. If on a subsequent examination, it is believed that the dog is receiving too much medication (poor appetite, for example) the dose can be reduced to 2-3 doses weekly. However, if the clinical signs begin to recur, if the urine specific gravity is <1.020, or if the post-acth cortisol is >5.5 µg/dl, then the dog should receive medication 5-6 days per week. In either scenario, the dog should be rechecked in 1-3 months and the process repeated. In geographic areas where ACTH is unavailable or prohibitively expensive, dogs with PDH can be treated and monitored long-term with o,p -DDD safely. Owner opinion is key is making dose adjustments. Well controlled dogs usually have home-caught urine that has a specific gravity > If an owner begins to observe recurrence of clinical signs in a pet whose specific gravity is <1.020, increase in dose is likely required. One should also obtain a morning serum cortisol from the dog before it is treated. Cortisol concentrations <1.5 µg/dl would indicate that medication be discontinued for a period. Concentrations above this should be viewed as inconclusive. MEDICAL THERAPY USING KETOCONAZOLE, RETINOIC ACID, CABERGOLINE In addition to its antifungal activity, ketoconazole (Nizoral) has been shown to interfere with gonadal and adrenal steroid synthesis. In comparison to o,p -DDD and trilostane, responses to ketoconazole have been inconsistent, relatively expensive, and rarely employed in the United States. However, in countries where o.p -DDD and trilostane are unavailable, use of ketoconazole, usually in combination with one of these other drugs has been efficacious (Perez-Alenza and Melian, 2016). MEDICAL THERAPY USING TRILOSTANE Background, Action, Efficacy and Safety as Compared with o,p -DDD Trilostane was first synthesized and used in the 1960 s, with generally poor results, for the treatment of hyperadrenocorticism in people. Like the disappointing results with o,p -DDD in people but excellent response in dogs, trilostane has followed a similar path. It began to be used for the treatment of dogs with naturally occurring hyperadrenocorticism in the 1990 s. Since then, a number of studies have been published demonstrating the excellent sensitivity of dogs with naturally occurring hyperadrenocorticism to trilostane. It is now licensed for veterinary use in countries
4 around the world. Trilostane, a synthetic steroid analogue, interferes with the enzyme 3beta-HSD. As an enzyme blocker, trilostane inhibits adrenocortical synthesis of progesterone and its end-products, including cortisol and aldosterone. The advantages of trilostane over o,p -DDD are its efficacy in dogs with either PDH or ATH and that it s use is licensed by many countries. Is the drug more effective than o,p -DDD? Effectiveness in dogs with PDH is similar with either drug, but trilostane is an unequivocally more effective treatment for dogs with ATH. Is trilostane safer than o,p -DDD? Either drug can be under dosed, which results in continuing clinical signs. Either drug can be over dosed, which can result in signs that range from a mild decrease in appetite to severe iatrogenic hypoadrenocorticism, crisis, and death. Since o,p -DDD is cytotoxic, adverse effects are expected persist. Since trilostane is an enzyme blocker, adverse effects would be expected to quickly dissipate. However, adverse side effects have persisted in many trilostane over dosed dogs, and some have had adrenocortical necrosis. It is likely that trilostane is more expensive than o,p -DDD in most countries. Monitoring response to therapy is similar for both. Current Availability, Compounding Pharmacies Trilostane is available commercially as 5, 10, 30, 60, and 120 mg capsules in most countries and marketed under the brand name Vetoryl. Use of trilostane manufactured by compounding pharmacies is not supported by published studies and is not recommended. General Approach Once medication is started (always by owners in the home environment) owners should be phoned every day, just as with o,p -DDD to be certain that serious side effects have not been seen and to remind owners that this drug can be lethal if given in too high a dose. Trilostane-treated dogs should be rechecked after about 7 days of therapy. The protocol we now recommend on days of a scheduled veterinary examination are for the owner to collect a urine sample from their dog that morning. The dog should then be fed and the trilostane administered. Dog and urine should be brought to the veterinarian about 2 hours later. The ACTH response test should be started 2 to 3 hours after trilostane administration and the urine assessed for specific gravity and glucose. From this time forward, the same starting time (post trilostane administration) should be employed for every ACTH stimulation test. The goal in therapy is to have an owner state that their dog is improved in the shortterm (first weeks) and normal in the long-term (after 4 to 8 weeks). To aid in achieving this goal, urine specific gravity should be >1.020 and the post-acth serum cortisol concentration should be between 1.5 and 5.5 µg/dl. If the post-acth serum cortisol concentration is <1.5 µg/dl, the dose given BID should be reduced by about 50%. If the post-acth serum cortisol concentration is >5.5 g/dl, the dose given BID should be increased by ~ 25%. If the post-acth serum cortisol concentration is > 1.5 and < 5.5 g/dl, and the urine is >1.020, continue the dose being given. However, if the post- ACTH serum cortisol concentration is > 1.5 and < 5.5 g/dl, and the urine is <1.020, then the veterinarian should advise the owner that the drug will be more effective given three times daily. Most dogs treated using this protocol have an excellent response and ultimately receive 0.2 to 1.0 mg/kg BID. Goals of Therapy: Dogs with Obvious Signs versus Dogs with Questionable Signs As with o,p -DDD, the use of trilostane should be limited to dogs with obvious clinical signs and appropriate laboratory and imaging results. The goal in therapy: make the owner happy. In other words, resolving clinical signs is the best measure of success in resolving biochemical and other issues associated with chronic circulating excesses of cortisol. If a dog is diagnosed with naturally occurring hyperadrenocorticism, but without owner perceived obvious clinical signs, the diagnosis must be questioned. Cushing s is a clinical syndrome, never solely biochemical. No veterinarian should treat any dog for this condition unless being absolutely convinced that treatment would be recommended if the dog were their personal pet. Also, it can be beneficial to remember that naturally occurring hyperadrenocorticism is a chronic progressive condition. Whenever one is unsure if a particular dog really has this condition, whether a particular dog should be treated, it is best to wait 1 12 months to observe. Dogs with naturally occurring hyperadrenocorticism progressively exhibit worsening signs of polyuria, polydipsia, polyphagia, hair loss, muscle weakness, etc. If such an approach is taken, it is important to understand that progression does not affect treatment success rate, rather, it assures that treatment is employed for the correct condition.
5 Protocol: Initial and Continuing Dose It is recommended that all dogs treated with trilostane begin at about mg/kg, twice daily. The 0.3 to 0.5 mg/kg BID dose is for dogs less than 15 kg and the 0.1 to 0.3 mg/kg BID dose is for dogs weighing more than 20 kg. There is no loading dose or induction phase of treatment with trilostane. In addition, once a satisfactory dose is established, it usually does not change significantly unless the diet or health of the dog changes. The veterinary clinician begins trilostane in a search for the dose and frequency best for the dog being treated. Ideally, the initial dose would be too low and the inadequate response would allow the dose to be progressively raised until that needed by the individual patient is attained. This would also be the best protocol for avoiding serious adverse side effects. Our experience to date is that these low doses are not only beneficial, but the clinical signs of polyuria, polydipsia, polyphagia, panting, and inactivity resolve within weeks in some dogs on these low dose protocols. We recommend that trilostane therapy always be initiated at home, on a Sunday, with the owner administering the BID dose after feeding their dog. The owner should receive thorough information on the actions of trilostane and instructed to begin reducing their dog s food allotment by one-third beginning one or two days before treatment is begun. In other words, we have owners give their dog one-third of its normal food allotment twice daily, beginning on a Friday or Saturday. This should make the typical polyphagic Cushing s dog even more hungry. NOTE: NO DOG WITH A POOR APPETITE SHOULD EVER RECEIVE THIS DRUG! After the first 7 to 10 days of treatment, normal quantities of food should again be given. Trilostane administration should be continued twice daily for about 7-10 days until the first recheck. The owner should be instructed to measure their dog s daily water consumption and to note when it approaches 60 ml/kg/day. Owners should also observe their dog s appetite to determine if the polyphagia is resolving by seeing that their dog simply takes longer to consume a meal. Partial or complete inappetence, vomiting, or diarrhea would indicate that the dog has been over dosed or that a serious concurrent condition has developed. Any worrisome change should lead to the owner stopping therapy and contacting their veterinarian. The goal is simply to have a dog s appetite return to normal. The earliest and single most reliable and consistent indicator for a positive response to therapy is reduction of appetite, often noted within days of starting trilostane. Water intake in polydipsic dogs decreases, in more than 90% of dogs, within 5 to 10 days. In all, response takes a few days or weeks. Ideally, it would require about days to establish an appropriate dose, but improvement has been seen far quicker and more consistently faster than this. Monitoring Laboratory Variables Veterinarians have blood, urine, blood pressure, imaging, and culture testing available. Any test may be of importance in monitoring specific individuals. In general, it is wise to assess BUN, creatinine, sodium and potassium at any recheck, since these parameters could indicate need for reconsidering therapy. Hyperkalemia, hyponatremia, or azotemia should prompt discontinuing treatment. As a dog is treated, veterinarians gain a sense as to what should be assessed, but there is no specific guideline we recommend, aside from recheck every 4 months, once stability is achieved. Monitoring with ACTH Stimulation Timing the Stimulation Test. To support owner observations, veterinary recheck examinations are quite valuable in fine tuning trilostane treatment to the individual. On the morning of the scheduled veterinary recheck, the owner should collect a free-catch urine sample from the dog, feed as usual and administer the trilostane. About 2 hours after trilostane dosing, the dog should be seen by the veterinarian. An ACTH stimulation test should be started 2 to 3 hours after trilostane was given. That time point for starting the stimulation test after trilostane should be used for every subsequent test. In other words, if the test is begun at 2.5 hours, all ACTH stimulation tests for that dog should be started 2.5 hours after trilostane. Trilostane peak effect in most dogs is 2-3 hours after administration. We have not only shown significant reduction in trilostane effect when comparing stimulation tests started 3 versus 9 hours after trilostane, but we have demonstrated significant difference when comparing tests begun 2 versus 4 hours. By 4 hours, trilostane effect begin to dissipate in most dogs and by 9 hours it is likely having little effect. Thus, tests started just an hour or 2 earlier or later can significantly change results obtained. Also, this is the reason for using twice daily dosing initially.
6 Employing Stimulation Test Results to Determine Dose. The ACTH stimulation test result is used to determine trilostane dose. In general, if the post-acth plasma cortisol is about 2 to 5.5 µg/dl, trilostane dose is good. If the cortisol concentration is lower, the dose should be decreased. If the cortisol concentration is higher, the dose of trilostane may need to be increased. If the owner is satisfied with their dog s progress, rather than raise a dose, one may wait and observe. If the owner is still observing clinical signs, even if less pronounced, the dog may benefit from a dose increase. Employing Urinalysis to Determine Frequency of Trilostane Administration. Collected urine should always be assessed for glucose and the other components of a dip-stick. This discussion assumes urine negative for glucose. If positive, the dog has diabetes mellitus and will likely require exogenous insulin. Also, before employing the urine specific gravity as a component for adjusting dose, the post-acth plasma cortisol concentration should be in the range of 2 to 5.5 µg/dl. Once that is achieved, urine specific gravity can be used to determine the best dosing frequency. If the owner is pleased with response to treatment, the stimulation results acceptable and urine specific gravity >1.020, no change in dose or frequency is made. In this scenario, dogs receiving trilostane TID can be tried on BID, those receiving the drug BID can be tried on a once daily regimen. However, if the stimulation results are acceptable (2 to 5.5 µg/dl) but an owner is continuing to observe polyuria and other clinical signs of Cushing s syndrome in a dog whose specific gravity is <1.020, the duration of trilostane effect is likely too brief to resolve the condition. In these dogs, we recommend increasing the frequency while slightly decreasing each dose. If possible, when changing from once to twice daily or twice to three times daily, each dose should be about 10-20% less than currently being employed. About 20% of our long-term trilostane-treated dogs are treated once daily, with about 70% and 10% treated BID or TID, respectively. The Formula for Long-Term Success. A formula for how to determine who needs a dose adjustment and what kind is needed should be heavily tilted to owner opinion. Also, only dogs described as having a ravenous or excellent appetite should be treated. Successful management of Cushing s is always associated with appetite reduction. If a dog has a poor appetite, Cushing s is the least important concern. Owners are best at determining excellent response as opposed to an over or under dosage. Unreliable owners negatively impact treatment success. Use of urinalysis and urine specific gravity is slightly less important. ACTH stimulation test results should be the third and least important determinant, unless results are <1.5 µg/dl, a scenario in which every dog should have their dose reduced. Monitoring without ACTH Stimulation In geographic areas where ACTH is unavailable or prohibitively expensive, dogs with hyperadrenocorticism can still be treated and monitored, long-term, safely. Owner opinion is key is making dose adjustments, together with home-caught urine specific gravity and a morning, pre-treatment, plasma cortisol. Well controlled dogs usually have home-caught urine that has a specific gravity > If an owner begins to observe recurrence of clinical signs in a pet whose specific gravity is <1.020 and the plasma cortisol is >5.5 µg/dl, increase in dose is required. If the specific gravity is <1.020 and the plasma cortisol is µg/dl, increase in frequency is required. SURGERY: ADRENALECTOMY Adrenalectomy may be unilateral for an adrenocortical tumor or bilateral as a mode of therapy for PDH. It is recommended that this surgery be performed by specialists and in facilities capable of handling the potential postoperative complications. Once the diagnosis of hyperadrenocorticism due to an adrenal tumor has been confirmed, attempts should be made to localize the tumor and rule out metastasis or vascular invasion. Methods for tumor localization include abdominal radiographs, ultrasonography, CT scans, and gamma camera imaging. Ultrasonography has proven to be our most valuable and cost effective aid in tumor localization and for detecting vascular invasion or metastasis. If metastasis is suspected, an ultrasound guided biopsy can be performed to confirm this suspicion. Thoracic radiographs should also be evaluated for metastatic disease in the lung parenchyma.
Naturally occurring hyperadrenocorticism is a wellrecognized
Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism Edward C. Feldman, dvm, dacvim Objective To evaluate effectiveness and
More informationOverview. Clinical signs. Will you treat? Owner willing to treat? Surgical vs. Medical. Medical options
Part II (cushing s disease is hard to diagnose) Cushing s Disease Is Easy To Treat Why test? When to test? How to test? Will you treat? How to treat? Overview Thomas Schermerhorn, VMD, DACVIM(SAIM) Kansas
More informationHudson, a 10-year-old MC Cocker spaniel, was referred for evaluation of severe polyuria and polydipsia (PU/PD) of 3 months in duration...
VCAWLAspecialty.com David Bruyette, DVM, DACVIM Hudson, a 10-year-old MC Cocker spaniel, was referred for evaluation of severe polyuria and polydipsia (PU/PD) of 3 months in duration... 1. Physical Examination
More informationRestore life and vitality in your dog. Feel the same results as an owner.
Restore life and vitality in your dog. Feel the same results as an owner. Your dog, Cushing s syndrome and you This booklet has been designed to help answer questions that you may have about Cushing s
More informationRestore life and vitality in your dog. Feel the same results as an owner.
Restore life and vitality in your dog. Feel the same results as an owner. Your dog, Cushing s syndrome and you This booklet has been designed to help answer questions that you may have about Cushing s
More informationA New Approach to Canine Hyperadrenocorticism
A New Approach to Canine Hyperadrenocorticism Jinelle Webb DVM, MSc, DVSc, Diplomate ACVIM Pathophysiology ACTH-secreting pituitary tumour (PDH) Cortisol-secreting adrenal tumour (FAT) Result of both is
More informationTreat their Cushing s Syndrome. Help restore their vitality. Dechra Veterinary Products April 2015
Treat their Cushing s Syndrome. Help restore their vitality. www.dechra-us.com Dechra Veterinary Products April 2015 Dechra Veterinary Products US and the Dechra D logo are registered trademarks of Dechra
More informationCOMPLICATED CUSHING S CASES AND CONCURRENT CONDITIONS
Vet Times The website for the veterinary profession https://www.vettimes.co.uk COMPLICATED CUSHING S CASES AND CONCURRENT CONDITIONS Author : Gerard Mclauchlan, Ian Ramsey Categories : Vets Date : August
More information(trilostane) What is Cushing s Syndrome?
(trilostane) What is Cushing s Syndrome? T E C H N I C A L B R O C H U R E What is Cushing s Syndrome? Hyperadrenocorticism, or Cushing s syndrome, is one of the most commonly diagnosed canine endocrine
More informationTreatments for pituitary and adrenal-dependent Cushing s
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatments for pituitary and adrenal-dependent Cushing s Author : KAREN CRAWFORD, REBECCA LITTLER Categories : Vets Date :
More informationHyperadrenocorticism: Diagnosis and Treatment
Hyperadrenocorticism: Diagnosis and Treatment Jinelle Webb DVM, MSc, DVSc, Diplomate ACVIM Pathophysiology ACTH-secreting pituitary tumour (PDH) Cortisol-secreting adrenal tumour (FAT) Result of both is
More informationFederal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
USA Product Label http://www.vetdepot.com DECHRA VETERINARY PRODUCTS Distributed by DECHRA VETERINARY PRODUCTS 7015 COLLEGE BLVD., STE. 525, OVERLAND PARK, KS, 66211 Telephone: 913-327-0015 Toll-Free:
More informationCanine Cushings Syndrome: Diagnostic Approaches and Treatment Options
Canine Cushings Syndrome: Diagnostic Approaches and Treatment Options Jinelle Webb DVM, MSc, DVSc, Diplomate ACVIM Pathophysiology ACTH-secreting pituitary tumour (PDH) Cortisol-secreting adrenal tumour
More informationCanine Cushing s Case Files: The ins and outs of detection and
Canine Cushing s Case Files: The ins and outs of detection and treatment 01CS-VET0001-0615 Sponsored by Dechra Veterinary Products Canine Cushing s Case Files: The Ins and Outs of Detection and Treatment
More informationEQUINE CUSHING S DISEASE
EQUINE CUSHING S DISEASE (PPID) The facts What is Equine Cushing s Disease? Equine Cushing s Disease, also known as Pituitary Pars Intermedia Dysfunction (PPID), is a common condition affecting older horses
More information- Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.
MERIAL LTD. USA Product Label http://www.vetdepot.com 3239 SATELLITE BLVD., DULUTH, GA, 30096 Telephone: 888-637-4251 Website: www.merial.com GASTROGARD Merial (omeprazole) Oral Paste for Equine Ulcers
More informationHousesoiling Dogs Basics
Housesoiling Dogs Basics OVERVIEW Urinating and/or defecating (having a bowel movement), as a means of eliminating or marking territory, in a location that the owner considers inappropriate GENETICS Some
More informationChristie Ward - The Question of Cushings
Many horse people are familiar with the classical symptom of advanced Cushing's disease in horses: a shaggy coat that refuses to shed out in the spring. But did you know that this hormonal disease can
More informationCOLLEGE OF VETERINARY MEDICINE
Title: A randomized, masked, placebo controlled field study to determine efficacy and safety of Paccal Vet in dogs with non resectable (or unresected) mammary carcinoma of stage III-V 1. Why is the study
More informationSINGLE ANNUAL IMPLANT
Manage pet ferret adrenal cortical disease with a SINGLE ANNUAL IMPLANT NOT APPROVED BY FDA Legally marketed as an FDA Indexed Product under MIF 900-013. FOR USE IN FERRETS ONLY. Extra-label use is prohibited.
More informationAssociated Terms: Breast Cancer, Radical Mastectomy, Mastectomy, Mammectomy, Mammary Adenocarcinoma
Associated Terms: Breast Cancer, Radical Mastectomy, Mastectomy, Mammectomy, Mammary Adenocarcinoma The term "ACVS Diplomate" refers to a veterinarian who has been board certified in veterinary surgery.
More informationCanine hyperadrenocorticism management
SMALL ANIMAL I CONTINUING EDUCATION Canine hyperadrenocorticism management Dr Christine Griebsch DipECVIM-CA, University Veterinary Teaching Hospital Sydney, Australia, discusses management of canine hyperadrenocorticism
More informationDECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC Dr Alfa 1. Complaint from Miss Bravo
DECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC16-26 Introduction Dr Alfa 1 Complaint from Miss Bravo 1. A Complaints Assessment Committee (CAC)
More informationUnited Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS (Reference Member State) DECENTRALISED PROCEDURE
United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS (Reference Member State) DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL
More informationAUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS. Sample Exam Questions. Veterinary Practice (Small Animal)
AUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS Sample Exam Questions Veterinary Practice (Small Animal) Written Examination (Component 1) Written Paper 1 (two hours): Principles of Veterinary
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More informationWhat Veterinarians Should Tell Clients About Pain Control and Their Pets
What Veterinarians Should Tell Clients About Pain Control and Their Pets by Michele Sharkey, DVM, MS, Office of New Animal Drug Evaluation; Margarita Brown, DVM MS, Office of Surveillance and Compliance;
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationPresenting Complaint: Her owners were concerned because she seemed to be losing weight despite having a
AVTCP Case Report # 1 Case Log# 45 Hyperthyroidism with Concurrent Chronic Kidney Disease (CKD) Suzie Q. Technician, CVT Signalment: Maya is a 3 kg 15-year-old spayed female Domestic Shorthair. Presenting
More informationSUMMARY OF PRODUCT CHARACTERISTICS. KELAPRIL 2.5 mg, film coated tablets for dogs and cats [FR] KELAPRIL 2,5 film coated tablets for dogs and cats
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT KELAPRIL 2.5 mg, film coated tablets for dogs and cats [FR] KELAPRIL 2,5 film coated tablets for dogs and cats 2. QUALITATIVE
More informationNSAIDs: the Past, Present, and Future
NSAIDs: the Past, Present, and Future Resident Seminar - November 2017 Lisanne Gallant, DVM Large Animal Medicine Resident Outline Physiology Review Use in Large Animals Adverse Effects Cases The Future
More informationSenior Pet Care and Early Disease Detection
Senior Pet Care and Early Disease Detection Thanks to advances in veterinary medicine, pets are living longer than ever before. However, with this increased lifespan comes an increase in the types of ailments
More informationUnited Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS (Reference Member State) MUTUAL RECOGNITION PROCEDURE
United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY
More informationEPAR type II variation for Metacam
23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents
More informationDon t let arthritis slow down your dog!
Don t let arthritis slow down your dog! abcd DOG CAT ACUTE CHRONIC PERIOPERATIVE INJECTABLE ORAL SUSPENSION CHEWABLE Keeping your dog in the prime of life Is your dog at risk of developing arthritis? As
More informationIndicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs.
Zoetis UK Limited Telephone: 0845 300 8034 Website: www.zoetis.co.uk Email: customersupportuk@zoetis.com Apoquel film-coated for dogs Species: Therapeutic indication: Active ingredient: Product: Product
More informationGastric Dilatation-Volvulus
Gastric Dilatation-Volvulus The term "ACVS Diplomate" refers to a veterinarian who has been board certified in veterinary surgery. Only veterinarians who have successfully completed the certification requirements
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Zubrin 50 mg oral lyophilisates for dogs Zubrin 100 mg oral lyophilisates for dogs Zubrin 200 mg oral lyophilisates
More informationSpontaneous hyperadrenocorticism (HAC) is one of the
J Vet Intern Med 2005;9:80 85 A Comparison of the Survival Times of Dogs Treated with Mitotane or Trilostane for Pituitary-Dependent Hyperadrenocorticism E.N. Barker, S. Campbell, A.J. Tebb, R. Neiger,
More informationUnderstanding your pet s LIVER CONDITION
Understanding your pet s LIVER CONDITION Why is the liver so important? What causes liver disease in dogs and cats? The liver is one of the largest organs in your pet s body, and it s vital for their good
More informationMy cat has kidney problems and food hypersensitivity what do I do now?
TROVET Renal (Venison), complete, easily digestible, hypoallergenic dietary food for adult cats with an impaired kidney function My cat has kidney problems and food hypersensitivity what do I do now? reliable
More informationHope for Healing Liver Disease in Your Dog. Quick Start Guide. by Cyndi Smasal
Hope for Healing Liver Disease in Your Dog Quick Start Guide by Cyndi Smasal Copyright 2004 by Cyndi Smasal All Rights Reserved. No part of this book may be reproduced, stored in a retrieval system, or
More informationElanco Osurnia US. New Case - Pet Owner
Elanco Osurnia US New Case - Pet Owner Elanco Osurnia US Recheck - Pet Owner Elanco Osurnia US Recurring - Pet Owner 617786 USA 921849 Otic gel Antibacterial, antifungal, anti-inflammatory For Otic Use
More informationSincerely, Patrick Melese MA, DVM, DACVB (Behavior) and the staff of the Veterinary Behavior Consultants.
Dear Colleague: Thank you for your request for referral supplies to help clients obtain specialty veterinary behavioral medicine services. For 30 years now (VBC) has been seeing clients with companion
More informationDosing Your Cat with Azithromycin Pediatric Suspension. By Lorraine Shelton
Dosing Your Cat with Azithromycin Pediatric Suspension By Lorraine Shelton To join a community of cat fanciers and health professionals interested in cattery related health issues, visit http://groups.yahoo.com/group/fanciershealth
More informationHeartworm Disease in Dogs
Kingsbrook Animal Hospital 5322 New Design Road, Frederick, MD, 21703 Phone: (301) 631-6900 Website: KingsbrookVet.com What causes heartworm disease? Heartworm Disease in Dogs Heartworm disease or dirofilariasis
More informationAcute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs
Acute Hemorrhagic Diarrhea Syndrome (AHDS) A Cause of Bloody Feces in Dogs No dog parent wants to clean up diarrhea. Cleaning up bloody diarrhea is even more unpleasant. Unfortunately, the development
More informationTreatment of septic peritonitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic
More informationCaution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
BOEHRINGER INGELHEIM VETMEDICA, INC. USA Product Label http://www.vetdepot.com 2621 NORTH BELT HIGHWAY, ST. JOSEPH, MO, 64506 2002 Telephone: 800 325 9167 Fax: 816 236 2717 Email: www.bi vetmedica.com
More informationNon-steroidal anti-inflammatory drugs (NSAIDs) are used widely to relieve pain, with or without
May 2013 Contents About NSAIDs What about COXselectivity? How effective are NSAIDs? Adverse effects of NSAIDs How frequent are the adverse effects of NSAIDs? General prescribing guidelines for NSAIDs What
More informationIs Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dog Diagnosed With a Degenerative Joint Process?
Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dog Diagnosed With a Degenerative Joint Process? A Knowledge Summary by Adam Swallow BVSc MRCVS 1* 1 University of Bristol * Corresponding
More informationSpontaneous hyperadrenocorticism (HAC) is a consequence
J Vet Intern Med 2014;28:481 487 Clinical Findings, Diagnostic Test Results, and Treatment Outcome in Cats with Spontaneous Hyperadrenocorticism: 30 Cases S.Y. Valentin, C.C. Cortright, R.W. Nelson, B.M.
More informationNEW In-Clinic Instrument Range Package Now Available
ASAP LABORATORY NEWS FEBRUARY 2015 Hi everyone Please find below the latest ASAP news. NEW In-Clinic Instrument Range Package Now Available ASAP is pleased to announce the launch of a collaboration with
More informationHEARTWORM DISEASE AND THE DAMAGE DONE
HEARTWORM DISEASE AND THE DAMAGE DONE Stephen Jones, DVM There are now more months of the year where environmental conditions favor mosquito survival and reproduction. Warmer temperatures Indoor environments
More informationSpontaneous hyperadrenocorticism (HAC) is a
Standard Article J Vet Intern Med 2016;30:1637 1641 Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism C. Aldridge, E.N. Behrend, R.J. Kemppainen,
More informationMetacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.
Metacam The Only NSAID Approved for Cats in the US John G. Pantalo, VMD Professional Services Veterinarian Think easy. Think cat. Think METACAM. Today s Agenda New pain management guidelines for cats Only
More informationDear Sweetie, I m so glad to hear you are doing much better after your cleaning!
Niles Knows Dear Sweetie, I m so glad to hear you are doing much better after your cleaning! Dear Niles, I just wanted to say thank-you for being there to comfort me during my dental cleaning. I was a
More informationThe Aging Dog. General Information
The Aging Dog Clermont Animal Hospital, Inc. General Information Like older humans, aging dogs are at an increased risk for a number of diseases and health problems. Research has shown that dogs over the
More informationDear Doctor: Our sincerest thanks, Stephen A. Connell, DVM Director, Technical, Academic and Consumer Services Elanco Companion Animal Health
Dear Doctor: As a trained professional, you understand the loss of a pet is incredibly difficult. Every pet owner responds differently as they grieve. We believe the recent negative media coverage of Trifexis
More informationDOG 4 CARING FOR THE OLDER DOG
DOG 4 CARING FOR THE OLDER DOG As with people, dogs slow down with age. They may want to take less exercise and start to put on weight. Some dogs become friendlier, and want to spend more time with their
More informationA Pet Owner s Guide to Joint Health for Dogs
A Pet Owner s Guide to Joint Health for Dogs What is Cosequin? Cosequin is a patented, scientifically researched nutritional supplement dispensed by thousands of veterinarians since 1992 to help dogs maintain
More informationDIAGNOSIS AND MANAGEMENT OF CHOLECYSTITIS IN DOGS
Int. J. Agric.Sc & Vet.Med. 2014 K Satish Kumar and D Srikala, 2014 Research Paper ISSN 2320-3730 www.ijasvm.com Vol. 2, No. 3, August 2014 2014 www.ijasvm.com. All Rights Reserved DIAGNOSIS AND MANAGEMENT
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationDelayed Prescribing for Minor Infections Resource Pack for Prescribers
Delayed Prescribing for Minor Infections Resource Pack for Prescribers Background: Antibiotic resistance is an alarming threat to modern healthcare, and infectious illness remains a major global threat
More informationMedicine / Pharmaceuticals CATALOGUE
Medicine / Pharmaceuticals CATALOGUE YOUR COMPLETE VETERINARY SUPPLY AND SUPPORT SOLUTION Cats / 250mg x 100 tablets 500mg x 100 tablets CLAVET TABLETS E000973 E000981 Indicated for the treatment of infections
More informationMetacam 1.5 mg/ml oral suspension for dogs
Metacam 1.5 mg/ml oral suspension for dogs Species:Dogs Therapeutic indication:pharmaceuticals: Neurological preparations: Analgesics, Other NSAIDs, Locomotor (including navicular and osteoarthritis) Active
More informationJoint Health Supplement
Joint Health Supplement A Pet Owner s Guide to Joint Health for Dogs What is Cosequin? Cosequin is a patented, scientifically researched nutritional supplement dispensed by thousands of veterinarians for
More informationTHE IMPORTANCE OF QUALITY IN COMPOUNDED VETERINARY MEDICINES
THE IMPORTANCE OF QUALITY IN COMPOUNDED VETERINARY MEDICINES GOOD MANUFACTURING PRACTICES On the 12th of June 2015 Bova was the first pharmacy in Australia to be granted a licence to manufacture veterinary
More informationThe complete guide to. Puppy Growth Charts. Puppy Growth Chart. Puppy Growth Chart. Dog s Name: Dog s Name: D.O.B. Dog s Name: Neuter Date:
The complete guide to s 9 8.-9kg 99. th Centile. th Centile. th Centile. th Centile. nd Centile. th Centile WPGC - What are the WALTHAM s? WALTHAM s are a user-friendly clinical tool designed for veterinary
More informationPREVENTIVE HEALTHCARE PROTOCOLS: SIMPLIFIED
cathealthy.ca PREVENTIVE HEALTHCARE PROTOCOLS: SIMPLIFIED WINTER 2015 ENDORSED BY: Cat Healthy Simplified Protocols ii TABLE OF CONTENTS: Summary of Key Points in Feline Preventive Healthcare 1 Kitten
More informationDuke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients
Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity
More informationTO ENSURE ADEQUATE ABSORPTION, ALWAYS ADMINISTER PROGRAM FLAVOR TABS IN CONJUNCTION WITH A NORMAL MEAL.
NOVARTIS ANIMAL HEALTH US, INC. USA Product Label http://www.vetdepot.com 3200 NORTHLINE AVE. SUITE 300, GREENSBORO, NC, 27408 Customer Service: 800 332 2761 Professional Services: 800 637 0281 Fax: 336
More informationXournals. Xournals. A Study on Addison s Disease in Dogs. Ritu Kumari 1. Abstract: Authors:
ISSN UA Volume 01 Issue 01 January-2019 A Study on Addison s Disease in Dogs Ritu Kumari 1 Available online at: www.xournals.com Received 19 th September 2018 Revised 16 th October 2018 Accepted 18 th
More informationWINN FELINE FOUNDATION AWARDS GRANTS FOR FELINE HEALTH STUDIES IN PARTNERSHIP WITH THE MILLER TRUST
Media Contact: Steve Dale (773) 525-8696 FOR IMMEDIATE RELEASE WINN FELINE FOUNDATION AWARDS GRANTS FOR FELINE HEALTH STUDIES IN PARTNERSHIP WITH THE MILLER TRUST Hillsborough, NJ, November 17, 2011: The
More informationWallenpaupack Veterinary Clinic 2425 Route 6 Hawley, PA Senior Pet Care
Wallenpaupack Veterinary Clinic 2425 Route 6 Hawley, PA 18428 570-226-2212 www.wallenpaupackvet.com Senior Pet Care Pets are considered seniors at age 7, although some giant breeds can be considered seniors
More informationCopper-Storage Liver Disease Basics
Copper-Storage Liver Disease Basics OVERVIEW Abnormal accumulation of copper in the liver, causing sudden (acute) inflammation of the liver (hepatitis) or long-term (chronic) hepatitis and eventually progressive
More informationPain Management in Racing Greyhounds
Pain Management in Racing Greyhounds Pain Pain is a syndrome consisting of multiple organ system responses, and if left untreated will contribute to patient morbidity and mortality. Greyhounds incur a
More informationPrescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):
Prescription Label Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long): Prescribing Veterinarian's Name & Contact Information: Refills: [Content to be provided
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationCanine Total Hip Replacement
Canine Total Hip Replacement Many factors enter into the decision to have a total hip replacement performed on your pet. You may have questions about the procedure. The answers to the most commonly asked
More informationPrescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):
Prescription Label Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long): Prescribing Veterinarian's Name & Contact Information: Refills: [Content to be provided
More informationFeline Vaccines: Benefits and Risks
Feline Vaccines: Benefits and Risks Deciding which vaccines your cat should receive requires that you have a complete understanding of the benefits and risks of the procedure. For this reason, it is extremely
More informationANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE
ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE Version 1.0 Date ratified June 2009 Review date June 2011 Ratified by Authors Consultation Nottingham Antibiotic Guidelines Committee
More informationGUIDELINES ON CHOOSING THE CORRECT ERADICATION TECHNIQUE
GUIDELINES ON CHOOSING THE CORRECT ERADICATION TECHNIQUE PURPOSE... 2 1. RODENTS... 2 1.1 METHOD PROS AND CONS... 3 1.1. COMPARISON BETWEEN BROUDIFACOUM AND DIPHACINONE... 4 1.2. DISCUSSION ON OTHER POSSIBLE
More informationRaw Meat Diet. Transcript:
Transcript: Raw Meat Diet Hi, this is Dr. Karen Becker, and today we re going to discuss why dogs and cats can eat raw meat. This is probably the most common question I get, especially from uneducated
More informationSeparation Anxiety Syndrome
Customer Name, Street Address, City, State, Zip code Phone number, Alt. phone number, Fax number, e-mail address, web site Separation Anxiety Syndrome Basics OVERVIEW A distress response of dogs (occasionally
More informationWeight Reduction in Dogs General Information
Weight Reduction in Dogs General Information Weight loss can be challenging for anyone: whether two- or four-legged! The great news is losing weight and getting in shape can add not only years to you or
More informationPrescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):
Prescription Label Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long): Prescribing Veterinarian's Name & Contact Information: Refills: [Content to be provided
More informationGranulosa Cell Tumor Associated with Occult Hyperadrenocorticism in a Yorkshire Terrier Bitch
Acta Scientiae Veterinariae, 2018. 46(Suppl 1): 320. CASE REPORT Pub. 320 ISSN 1679-9216 Granulosa Cell Tumor Associated with Occult Hyperadrenocorticism in a Yorkshire Terrier Bitch Priscilla Deluchi¹,
More informationAnesthesia Check-off Form
Anesthesia Check-off Form 5231 SW 91st Drive Gainesville, FL 32608 (352) 377-6003 The doctors and staff at Haile Plantation Animal Clinic would like to offer the most advanced medical care and services
More informationCANINE HEARTWORM DISEASE
! CANINE HEARTWORM DISEASE What causes heartworm disease? Heartworm disease (dirofilariasis) is a serious and potentially fatal disease in dogs. It is caused by a blood-borne parasite called Dirofilaria
More informationAmerican Ferret Association, Inc. PO Box 554 Frederick, MD FERRET-1
American Ferret Association, Inc. PO Box 554 Frederick, MD 21705-0554 1-888-FERRET-1 afa@ferret.org www.ferret.org ADRENAL DISEASE IN FERRETS Renee Gandolfi, DVM, ABVP Dipl. Castro Valley Companion Animal
More informationHealth Products Regulatory Authority. Dexa-ject 2 mg/ml solution for injection for cattle, horses, pigs, dogs and cats
1 NAME OF THE VETERINARY MEDICINAL PRODUCT Dexa-ject 2 mg/ml solution for injection for cattle, horses, pigs, dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per ml: Active substance: Dexamethasone
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Rycarfa 100 mg tablets for dogs (BE, DE, ES, FR, IE, IT, NL, PT, UK) Rycarfa vet 100 mg tablets for dogs (DK, FI) Carprox
More informationIntroduction to Canine and Feline Dispensing
SCSHP 2014 Annual Meeting Introduction to Canine and Feline Dispensing Clay Sprouse, BA, CPhT Piedmont Technical College A house is not a home without a pet. Unknown Animals are such agreeable friends
More informationCE West June 1-3, 2018 Wine Country Inn, Palisade, CO
CE West June 1-3, 2018 Wine Country Inn, Palisade, CO Tips and Tricks of the Trade: Practical Dermatology and Ophthalmology for the General Practitioner AGENDA Friday, June 1 5:00 6:00 PM Registration
More informationIrish Medicines Board
IRISH MEDICINES BOARD ACT 1995, as amended European Communities (Animal Remedies) (No. 2) Regulations 2007 VPA: 10988/081/002 Case No: 7007872 The Irish Medicines Board in exercise of the powers conferred
More informationVaccination. Why do I need to vaccinate my dog? many dogs don t survive. Several outbreaks of Parvovirus are reported in the UK each year.
Caring for your Dog This booklet will detail the most important aspects of dog healthcare and preventative care. Part of responsible dog ownership is ensuring all of the routine prevention is up to date.
More informationStreet 2: Owner s Address: City: State: Zip:
CLIENT SATISFACTION SURVEY CLIENT SATISFACTION SURVEY Date Of Your Visit: Please Indicate How You Would Rate Us Based On A Scale From 1 to 5, Where 5=Excellent And 1=Poor Professionalism Of Our Staff:
More informationCoccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets
Coccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets Infectious organisms are everywhere. Bacteria, viruses, and fungi threaten our pets every day. Some prefer specific environmental
More information